The following is a summary of “Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives,” published in the December ...

The following is a summary of “Introducing Neoadjuvant Immunotherapy for Colorectal Cancer: Advancing the Frontier,” ...

When this protein is expressed in the tumor microenvironment, it is picked up by the immune system’s T cells – the warrior cells that are supposed to destroy the cancer cells – suppressing ...

Early-onset head and neck squamous cell carcinoma (HNSCC) has been increasingly observed in recent years, exhibiting distinct tumor behavior and a unique tumor microenvironment (TME ... However, the ...

To this end, tumor angiogenesis and immune suppressive microenvironment tend to form positive feedback involving the interactions ... More importantly, the combination therapy of anti-angiogenesis and ...

Objective Investigating the effect of ferroptosis in the tumour microenvironment to identify combinatory ... Yet, this alone would not explain the unresponsiveness to checkpoint blockade of primary ...

Cancer treatment is undergoing a revolution, and immunotherapy is leading the charge. Unlike traditional methods like ...

BOSTON, MASSACHUSETTS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, ...